El-Mahdi A M, Turalba C I, Schellhammer P F, Peeples W J
Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):541-8. doi: 10.1016/0360-3016(84)90033-6.
In 1976 we began using a triple-course technique of external beam irradiation for localized carcinoma of the prostate. The treatment consisted of 2 courses of 20 Gy in 2 weeks to the pelvis and a third course of 20-25 Gy in 2-2 1/2 weeks as a boost to the prostate. A 2 week rest followed the first and second courses. The results of this treatment technique are reported on the first 50 patients who had been followed for at least 3 years. Although 96% of these patients developed bladder and/or bowel reactions, the majority of the symptoms were in the very mild to mild category, with only 2% severe reactions referrable to each organ. The incidence of late complications in this series compared favorably to those reported by other authors. Clinical local control was 96% while post-treatment needle biopsy performed on 22/50 patients yielded a negative rate of 86%. Those with Stages A and B disease had a negative biopsy rate of 94%. Three-year uncorrected disease-free survival for the whole group was 54%. This study has shown that with triple course external beam irradiation, excellent control of localized carcinoma of the prostate can be achieved with minimal acute morbidity.
1976年,我们开始采用外照射三线疗程技术治疗局限性前列腺癌。治疗方案包括:前两个疗程,在两周内对盆腔给予20 Gy照射;第三个疗程,在2至2.5周内给予20 - 25 Gy照射,作为对前列腺的强化照射。第一和第二个疗程后各休息两周。本文报告了采用该治疗技术的首批50例患者的治疗结果,这些患者均接受了至少3年的随访。尽管96%的患者出现了膀胱和/或肠道反应,但大多数症状为轻度至非常轻度,每个器官出现严重反应的患者仅占2%。该系列患者的晚期并发症发生率与其他作者报告的结果相比更优。临床局部控制率为96%,对50例患者中的22例进行治疗后穿刺活检,活检阴性率为86%。A期和B期疾病患者的活检阴性率为94%。整个组的三年未校正无病生存率为54%。本研究表明,采用三线疗程外照射,可以在急性发病率极低的情况下,实现对局限性前列腺癌的良好控制。